Follow The Filings

RPRX

Earnings company data as of 4:45 AM ET 10/31

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 1.18 — —
Rev $884.8M — —

Insider trades

Open-market buys and sales by RPRX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RPRX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $92.8M sold by 5 insiders under 10b5-1 plans
  1. Marshall Urist EVP, Research & Investments
    Planned sale
    $236K 4,126 shares at $57.10 100% of stake
    Traded Oct 5 Filed Oct 5
    ↗
  2. Marshall Urist EVP, Research & Investments
    Planned sale
    $239K 4,126 shares at $57.88 50% of stake
    Traded Sep 28 Filed Sep 30
    ↗
  3. Christopher Hite Chair
    Planned sale
    $5.9M 100,000 shares at $58.53 27% of stake
    Traded Sep 22 Filed Sep 24
    ↗
  4. Christopher Hite Chair
    Planned sale
    $6M 100,000 shares at $59.97 21% of stake
    Traded Aug 18 Filed Aug 19
    ↗
  5. Terrance P. Coyne CFO
    Planned sale
    $646K 11,002 shares at $58.68 100% of stake
    Traded Aug 13 Filed Aug 17
    ↗
  6. Marshall Urist EVP, Research & Investments
    Planned sale
    $508K 9,099 shares at $55.88 100% of stake
    Traded Jul 1 Filed Jul 2
    ↗
  7. Christopher Hite Chair
    Planned sale
    $7.3M 130,000 shares at $56.50
    Traded Jun 30 Filed Jul 2
    ↗
  8. Marshall Urist EVP, Research & Investments
    Planned sale
    $502K 9,098 shares at $55.18 50% of stake
    Traded Jun 24 Filed Jun 25
    ↗
  9. Christopher Hite Chair
    Planned sale
    $8.2M 150,000 shares at $54.40 21% of stake
    Traded Jun 23 Filed Jun 25
    ↗
  10. Terrance P. Coyne CFO
    Planned sale
    $3.5M 64,399 shares at $53.98 100% of stake
    Traded May 26 Filed May 28
    ↗
  11. Marshall Urist EVP, Research & Investments
    Planned sale
    $722K 13,684 shares at $52.75 43% of stake
    Traded May 20 Filed May 21
    ↗
  12. Marshall Urist EVP, Research & Investments
    Planned sale
    $726K 13,684 shares at $53.06 30% of stake
    Traded May 14 Filed May 15
    ↗
  13. Gregory Norden Director
    Planned sale
    $161K 3,045 shares at $53.00 1.6% of stake
    Traded May 14 Filed May 15
    ↗
  14. Terrance P. Coyne CFO
    Planned sale
    $1.7M 34,791 shares at $49.78 46% of stake
    Traded Apr 28 Filed Apr 30
    ↗
  15. Terrance P. Coyne CFO
    Planned sale
    $1.7M 34,791 shares at $48.33 51% of stake
    Traded Apr 1 Filed Apr 2
    ↗

Also filed in the last 12 months, not counted as buying or selling: 29 stock grants, 1 conversion, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 9 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.07 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 13 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.